🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Metabolomics in the Diagnosis and Treatment of Asthma in Children

Recruitingn/aAges 12 Years - 17 YearsAllI.M. Sechenov First Moscow State Medical Universi…
NCT07280364 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age from 12 to 17 years old * Confirmed diagnosis of asthma * Informed voluntary consent to participate in the study Exclusion Criteria: * age under 12 years * no established diagnosis of asthma * concomitant severe somatic, metabolic, and endocrine diseases * patient's withdrawal of informed consent
💊

What it tests

  • Standart medical treatment
📍

Where

1 site
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy